Select Page

Predictive Oncology CEO Raymond Vennare joins Natalie Stoberman from the Proactive newsroom to share the appointment of Dr. Bob Murphy to the company’s Scientific Advisory Board. Dr. Murphy is a pioneer in the field of machine learning and analytics for biological data. He is also an expert in developing algorithms and models to understand biological systems and relationships.

Predictive Oncology (NASDAQ: POAI) offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to advance molecules into medicine more confidently by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the world’s largest privately held biobank of over 150K tumor samples.